Skip to main content
Premium Trial:

Request an Annual Quote

Claremont BioSolutions Moves into Europe, Taiwan, S. Korea with Distribution Deals

NEW YORK (GenomeWeb News) – Molecular diagnostics products firm Claremont BioSolutions has signed deals to distribute its products in Europe, Taiwan, and South Korea.

The deals, announced on Thursday, are with Gentaur Molecular Products, based in Belgium; Ohhana Biotech in Taiwan; and Omics Biotech of South Korea, who will distribute Claremont's products for sample preparation, DNA isolation, and protein purification.

The distributors will sell Claremont's products to the academic, government, and biotech spaces. Financial and other terms of the deals were not disclosed.

Claremont is based in Upland, Calif., and develops and markets cell lysis, DNA and RNA extraction, and His-tagged protein purification kits and columns. In December the company announced distribution deals with Funakoshi covering Japan and with Bioquote covering the UK and Ireland.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.